Anticalcitonin: limited utility of a context-dependent biomarker demonstrated in another real-world data set
Clinical Infectious Diseases · 02.07.2026
DOI: 10.1093/cid/ciag396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 02.07.2026. Verfasst von Dan Ilges und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Mayo Clinic Arizona, Pheonix, AZ, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacy, Mayo Clinic Arizona, Pheonix, AZ, USA.
- Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN, USA.
- Department of Pharmacy Services, Mayo Clinic, Rochester, MN, USA.
- Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Dan Ilges, Aditya Shah, Ryan W Stevens
Zitieren
APA
Ilges, D., Shah, A., Stevens, R. W., & McCreary, E. K. (2026). Anticalcitonin: limited utility of a context-dependent biomarker demonstrated in another real-world data set. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag396
Vancouver
Ilges D, Shah A, Stevens RW, McCreary EK. Anticalcitonin: limited utility of a context-dependent biomarker demonstrated in another real-world data set. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag396
BibTeX
@article{Ilges2026,
author = {Ilges, Dan and Shah, Aditya and Stevens, Ryan W and McCreary, Erin K},
title = {Anticalcitonin: limited utility of a context-dependent biomarker demonstrated in another real-world data set},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag396}
}
EUVIMED